0001209191-20-064258.txt : 20201217
0001209191-20-064258.hdr.sgml : 20201217
20201217204407
ACCESSION NUMBER: 0001209191-20-064258
CONFORMED SUBMISSION TYPE: 3/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201211
FILED AS OF DATE: 20201217
DATE AS OF CHANGE: 20201217
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Bogue Zachary
CENTRAL INDEX KEY: 0001836157
FILING VALUES:
FORM TYPE: 3/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39781
FILM NUMBER: 201397733
MAIL ADDRESS:
STREET 1: 270 UNIVERSITY AVENUE
CITY: PALO ALTO
STATE: CA
ZIP: 94301
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: JNK Capital Management, LLC
CENTRAL INDEX KEY: 0001836273
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 3/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39781
FILM NUMBER: 201397734
BUSINESS ADDRESS:
STREET 1: 270 UNIVERSITY AVENUE
CITY: PALO ALTO
STATE: CA
ZIP: 94301
BUSINESS PHONE: 415-840-7337
MAIL ADDRESS:
STREET 1: 270 UNIVERSITY AVENUE
CITY: PALO ALTO
STATE: CA
ZIP: 94301
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: DCVC Bio, L.P.
CENTRAL INDEX KEY: 0001735069
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 3/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39781
FILM NUMBER: 201397735
BUSINESS ADDRESS:
STREET 1: 317 UNIVERSITY AVENUE, SUITE 200
CITY: PALO ALTO
STATE: CA
ZIP: 94301
BUSINESS PHONE: 415-840-7337
MAIL ADDRESS:
STREET 1: 317 UNIVERSITY AVENUE, SUITE 200
CITY: PALO ALTO
STATE: CA
ZIP: 94301
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: DCVC Bio GP, LLC
CENTRAL INDEX KEY: 0001735070
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 3/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39781
FILM NUMBER: 201397736
BUSINESS ADDRESS:
STREET 1: 317 UNIVERSITY AVENUE, SUITE 200
CITY: PALO ALTO
STATE: CA
ZIP: 94301
BUSINESS PHONE: 415-840-7337
MAIL ADDRESS:
STREET 1: 317 UNIVERSITY AVENUE, SUITE 200
CITY: PALO ALTO
STATE: CA
ZIP: 94301
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ZNM Capital Management, LLC
CENTRAL INDEX KEY: 0001836103
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 3/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39781
FILM NUMBER: 201397737
BUSINESS ADDRESS:
STREET 1: 270 UNIVERSITY AVENUE
CITY: PALO ALTO
STATE: CA
ZIP: 94301
BUSINESS PHONE: 415-840-7337
MAIL ADDRESS:
STREET 1: 270 UNIVERSITY AVENUE
CITY: PALO ALTO
STATE: CA
ZIP: 94301
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ocko Matthew
CENTRAL INDEX KEY: 0001836089
FILING VALUES:
FORM TYPE: 3/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39781
FILM NUMBER: 201397738
MAIL ADDRESS:
STREET 1: 270 UNIVERSITY AVENUE
CITY: PALO ALTO
STATE: CA
ZIP: 94301
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Stead Kiersten
CENTRAL INDEX KEY: 0001836117
FILING VALUES:
FORM TYPE: 3/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39781
FILM NUMBER: 201397739
MAIL ADDRESS:
STREET 1: 270 UNIVERSITY AVENUE
CITY: PALO ALTO
STATE: CA
ZIP: 94301
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AbCellera Biologics Inc.
CENTRAL INDEX KEY: 0001703057
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: A1
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2215 YUKON STREET
CITY: VANCOUVER
STATE: A1
ZIP: V5Y 0A1
BUSINESS PHONE: (604) 559-9005
MAIL ADDRESS:
STREET 1: 2215 YUKON STREET
CITY: VANCOUVER
STATE: A1
ZIP: V5Y 0A1
3/A
1
doc3a.xml
FORM 3/A SUBMISSION
X0206
3/A
2020-12-11
2020-12-11
0
0001703057
AbCellera Biologics Inc.
ABCL
0001735069
DCVC Bio, L.P.
270 UNIVERSITY AVENUE
PALO ALTO
CA
94301
0
0
1
0
0001735070
DCVC Bio GP, LLC
270 UNIVERSITY AVENUE
PALO ALTO
CA
94301
0
0
1
0
0001836103
ZNM Capital Management, LLC
270 UNIVERSITY AVENUE
PALO ALTO
CA
94301
0
0
1
0
0001836089
Ocko Matthew
270 UNIVERSITY AVENUE
PALO ALTO
CA
94301
0
0
1
0
0001836117
Stead Kiersten
270 UNIVERSITY AVENUE
PALO ALTO
CA
94301
0
0
1
0
0001836157
Bogue Zachary
270 UNIVERSITY AVENUE
PALO ALTO
CA
94301
0
0
1
0
0001836273
JNK Capital Management, LLC
270 UNIVERSITY AVENUE
PALO ALTO
CA
94301
0
0
1
0
Series A1 Preferred Shares
Common Shares
21052640
I
See footnote
Series A2 Preferred Shares
Common Shares
8023710
I
See footnote
Convertible Note
17.00
Common Shares
29411
I
See footnote
The Series A1 Preferred Shares and Series A2 Preferred Shares (collectively, the "Preferred Shares") are convertible into Common Shares at a 1:10 ratio into the number of Common Shares as shown in Column 3 at any time at the holder's election, and automatically upon the closing of the Issuer's initial public offering ("IPO") without payment of additional consideration. The Preferred Shares have no expiration date.
These securities are held by DCVC Bio, L.P. ("DCVC Bio"). DCVC Bio GP, LLC ("DCVC Bio GP") is the general partner of DCVC Bio and has sole voting and dispositive power with regard to the securities held by DCVC Bio. JNK Capital Management, LLC ("JNK") and ZNM Capital Management, LLC ("ZNM") are the managing members of DCVC Bio GP and share voting and dispositive power with respect to the securities held by DCVC Bio. The managing members of JNK and ZNM are Matthew Ocko, Zachary Bogue, John Hamer and Kiersten Stead. Matthew Ocko, Zachary Bogue, John Hamer and Kiersten Stead share voting and dispositive power with respect to the securities held by DCVC Bio.
(Continued from Footnote 2) Each of the Reporting Persons disclaims the existence of a "group" and disclaims beneficial ownership of such securities and this report shall not be deemed an admission that it is the beneficial owner of such securities, except to the extent of its indirect pecuniary interest therein, if any.
The convertible promissory note ("Convertible Note") has a maturity date of October 30, 2025 and the principal amount of the Convertible Note will convert upon the closing of the IPO into Common Shares at a conversion price equal to $17.00 per Common Share.
This amendment is being filed to add certain Reporting Persons that were inadvertently not included on the Form 3 initially filed. The holdings reported in this amendment are not new or revised but are being reported to gain access to the SEC's EDGAR filing system.
This is one of two Form 3s filed on the date hereof in respect of these securities. The Reporting Person for the other Form 3 is John Hamer.
DCVC Bio, L.P. By: DCVC Bio GP, LLC Its: General Partner By: ZNM Capital Management, LLC Its: Managing Member By: /s/ Matthew Ocko Matthew Ocko, Managing Member
2020-12-17
DCVC Bio GP, LLC By: ZNM Capital Management, LLC Its: Managing Member By: /s/ Matthew Ocko Matthew Ocko, Managing Member
2020-12-17
ZNM Capital Management, LLC By: /s/ Matthew Ocko Matthew Ocko, Managing Member
2020-12-17
Matthew Ocko /s/ Matthew Ocko
2020-12-17
Kiersten Stead /s/ Kiersten Stead
2020-12-17
Zachary Bogue /s/ Zachary Bogue
2020-12-17
JNK Capital Management, LLC, By: /s/ Kiersten Stead Kiersten Stead, Managing Member
2020-12-17